SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs1356410 | chr15:42142639 (GRCh38.p7) | T>C | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
KRT7 | 0.742 |
FOXE1 | 0.733 |
TPO | 0.727 |
IYD | 0.714 |
CASP14 | 0.713 |
KRTAP4-9 | 0.692 |
SCNN1B | 0.688 |
CALML5 | 0.681 |
WDR72 | 0.677 |
LCE3D | 0.674 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
FEZF2 | -0.317 |
MYH7B | -0.313 |
HHATL | -0.312 |
SCLY | -0.304 |
PLA2G6 | -0.299 |
LRRC45 | -0.296 |
ZNF775 | -0.295 |
SPAG8 | -0.295 |
FRS3 | -0.293 |
ASPDH | -0.293 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of PLA2G4F gene | 27153756 |
C075388 | beta-damascenone | beta-damascenone results in increased expression of PLA2G4F mRNA | 22982537 |
C006780 | bisphenol A | bisphenol A results in decreased expression of PLA2G4F mRNA | 25181051 |
C045463 | leflunomide | leflunomide results in increased expression of PLA2G4F mRNA | 28988120 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of PLA2G4F mRNA" | 20188158 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of PLA2G4F mRNA | 20813756 |
D013853 | Thioacetamide | Thioacetamide results in increased expression of PLA2G4F mRNA | 23411599 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of PLA2G4F mRNA | 20133372 |
D014520 | Urethane | Urethane results in decreased expression of PLA2G4F mRNA | 28818685 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of PLA2G4F gene | 29154799 |
C088658 | zoledronic acid | zoledronic acid results in decreased expression of PLA2G4F mRNA | 24714768 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004622 | lysophospholipase activity | - | TAS | - |
GO:0004623 | phospholipase A2 activity | - | IBA | 21873635 |
GO:0004623 | phospholipase A2 activity | - | TAS | - |
GO:0005509 | calcium ion binding | - | IBA | 21873635 |
GO:0005544 | calcium-dependent phospholipid binding | - | IBA | 21873635 |
GO:0008970 | phosphatidylcholine 1-acylhydrolase activity | - | TAS | - |
GO:0046872 | metal ion binding | - | IEA | - |
GO:0047498 | calcium-dependent phospholipase A2 activity | - | IBA | 21873635 |
GO:0047498 | calcium-dependent phospholipase A2 activity | - | IEA | - |
GO:0102567 | phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine) | - | IEA | - |
GO:0102568 | phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine) | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0001516 | prostaglandin biosynthetic process | - | IEA | - |
GO:0006644 | phospholipid metabolic process | - | TAS | - |
GO:0009395 | phospholipid catabolic process | - | IEA | - |
GO:0036148 | phosphatidylglycerol acyl-chain remodeling | - | TAS | - |
GO:0036149 | phosphatidylinositol acyl-chain remodeling | - | TAS | - |
GO:0036150 | phosphatidylserine acyl-chain remodeling | - | TAS | - |
GO:0036151 | phosphatidylcholine acyl-chain remodeling | - | TAS | - |
GO:0036152 | phosphatidylethanolamine acyl-chain remodeling | - | TAS | - |
GO:0046475 | glycerophospholipid catabolic process | - | IBA | 21873635 |
GO:0050482 | arachidonic acid secretion | - | IEA | - |
GO:0071236 | cellular response to antibiotic | - | IEA | - |
GO:0071407 | cellular response to organic cyclic compound | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005737 | cytoplasm | - | IBA | 21873635 |
GO:0005765 | lysosomal membrane | - | IEA | - |
GO:0005829 | cytosol | - | IBA | 21873635 |
GO:0005829 | cytosol | - | TAS | - |
GO:0031982 | vesicle | - | IBA | 21873635 |
GO:0031982 | vesicle | - | IEA | - |
GO:0032587 | ruffle membrane | - | IBA | 21873635 |
GO:0032587 | ruffle membrane | - | IEA | - |
KEGG ID | KEGG Term |
---|---|
hsa04666 | Fc gamma R-mediated phagocytosis |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-1430728 | Metabolism | TAS |
R-HSA-1482788 | Acyl chain remodelling of PC | TAS |
R-HSA-1482801 | Acyl chain remodelling of PS | TAS |
R-HSA-1482839 | Acyl chain remodelling of PE | TAS |
R-HSA-1482922 | Acyl chain remodelling of PI | TAS |
R-HSA-1482925 | Acyl chain remodelling of PG | TAS |
R-HSA-1483115 | Hydrolysis of LPC | TAS |
R-HSA-1483206 | Glycerophospholipid biosynthesis | TAS |
R-HSA-1483257 | Phospholipid metabolism | TAS |
R-HSA-556833 | Metabolism of lipids | TAS |
PMID | Title (Year) | Author | Journal |
---|